These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 4942003)

  • 41. Monoamineoxidase inhibition and insulin sensitivity.
    Adnitt PI
    J Endocrinol; 1968 Nov; 42(3):417-23. PubMed ID: 5250314
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effect of monoamine oxidase inhibitors on iris motility].
    Balacco-Gabrieli C; Scorcia G
    Minerva Oftalmol; 1971; 13(4):117-24. PubMed ID: 5145165
    [No Abstract]   [Full Text] [Related]  

  • 43. Early effects of monoamine oxidase inhibitors on dopamine metabolism and monoamine oxidase activity in the neostriatum of the rat.
    Javoy F; Youdim MB; Agid Y; Glowinski J
    J Neural Transm; 1973; 34(4):279-89. PubMed ID: 4149516
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect of monoamine oxidase inhibitors on qualitative alterations in enzymatic properties of mitochondrial monoamine oxidases.
    Abdel Samed MH; Akopyan ZI; Veryovkina IV; Kulygina AA; Gorkin VZ
    Biochem Pharmacol; 1971 Oct; 20(10):2571-7. PubMed ID: 5114498
    [No Abstract]   [Full Text] [Related]  

  • 45. N-substituted cyclopropylamines as monoamine oxidase inhibitors. Structure-activity relationships. Dopa potentiation in mice and in vitro inhibition of kynuramine oxidation.
    Mills J; Kattau R; Slater IH; Fuller RW
    J Med Chem; 1968 Jan; 11(1):95-7. PubMed ID: 4384132
    [No Abstract]   [Full Text] [Related]  

  • 46. [Effect of various antidepressive agents on brain monoamine oxidase activity].
    Gankina EM; Moskvitina TA; Gorkin VZ; Val'dman AV
    Biull Eksp Biol Med; 1982 Nov; 94(11):29-31. PubMed ID: 7150732
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of monoamine oxidase inhibitors on the disposition of intracisternally administered metaraminol-3H.
    Breese GR; Chase TN; Kopin IJ
    Biochem Pharmacol; 1970 Feb; 19(2):525-32. PubMed ID: 4396250
    [No Abstract]   [Full Text] [Related]  

  • 48. [Comparative data on the inhibition of the monoaminoxidase activity by the hydrazine group substances].
    Riabokon' NA; Grebennik LI
    Farmakol Toksikol; 1965; 28(5):608-12. PubMed ID: 5875829
    [No Abstract]   [Full Text] [Related]  

  • 49. Inhibition of monoamine oxidation in brain by monoamine oxidase inhibitors.
    Guha SR; Ghosh SK
    Biochem Pharmacol; 1970 Nov; 19(11):2929-32. PubMed ID: 5512700
    [No Abstract]   [Full Text] [Related]  

  • 50. The effects of monoamine oxidase inhibitors on spinal synaptic activity.
    Anderson EG; Baker RG; Banna NR
    J Pharmacol Exp Ther; 1967 Dec; 158(3):405-15. PubMed ID: 5299660
    [No Abstract]   [Full Text] [Related]  

  • 51. Interactions between monoamine oxidase inhibitors and sympathomimetic amines in the rat isolated vas deferens.
    Laporte J; Jané F; Valdecasas FG
    J Pharm Pharmacol; 1968 Feb; 20(2):148-9. PubMed ID: 4384539
    [No Abstract]   [Full Text] [Related]  

  • 52. [On the chromatographic purification and some properties of rat mitochondrial monoamine oxidase].
    Kliashtorin LB; Gridneva LI; Gorkin VZ
    Biokhimiia; 1966; 31(1):167-73. PubMed ID: 5982386
    [No Abstract]   [Full Text] [Related]  

  • 53. Letter: Monoamine tetrazolium reductase of rat heart mitochondria.
    Sen R; Parmar SS; Guha SR
    J Pharm Pharmacol; 1973 Oct; 25(10):835-7. PubMed ID: 4149751
    [No Abstract]   [Full Text] [Related]  

  • 54. Tryptamine: potentiation of its hyperthermic effect in rabbits by various monoamine oxidase inhibitors.
    Quock RM
    Pharmacol Res Commun; 1981 Mar; 13(3):281-6. PubMed ID: 6111091
    [No Abstract]   [Full Text] [Related]  

  • 55. A comparison of the effects of some monoamine oxidase (MAO) inhibitors with 5-hydroxytryptophan (5-HTP) and dihydroxyphenylalanine (DOPA) on spinal synaptic activity.
    Anderson EG; Baker R; Banna N
    Proc West Pharmacol Soc; 1966; 9():40-1. PubMed ID: 5958499
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects of imipramine, desipramine and monoamine oxidase inhibitors on the metabolism and psychomotor stimulant actions of d-amphetamine in mice.
    Lew C; Iversen SD; Iversen LL
    Eur J Pharmacol; 1971 May; 14(4):351-9. PubMed ID: 4400534
    [No Abstract]   [Full Text] [Related]  

  • 57. The effect of ethanol consumption on the sensitivity of rat brain monoamine oxidases to the inhibition by pargyline in vivo and in vitro.
    Panova NG; Axenova LN; Medvedev AE
    Neurobiology (Bp); 2000; 8(3-4):225-30. PubMed ID: 11225512
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effect of serotonin antagonists and monoamine oxidase inhibitors on the antineoplastic effect of serotonin].
    Mal'tseva LF
    Farmakol Toksikol; 1968; 31(6):735-8. PubMed ID: 5713590
    [No Abstract]   [Full Text] [Related]  

  • 59. Synthesis of some N-substituted eleostearic acid hydrazides as potential monoamine oxidase inhibitors.
    Hsu SY; Huang CL; Waters IW
    J Med Chem; 1973 May; 16(5):450-2. PubMed ID: 4146252
    [No Abstract]   [Full Text] [Related]  

  • 60. Mechanism of inhibition of beef liver mitochondrial monoamine oxidase by iproniazid.
    Gomes B
    Indian J Biochem Biophys; 1983 Apr; 20(2):96-9. PubMed ID: 6671669
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.